Sylvie Julien
- Ophthalmology top 0.5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Molecular Biology
- Cellular and Molecular Neuroscience top 10%
- Immunology
- Co-authors
- Ulrich SchraermeyerAntje BiesemeierTatjana TaubitzPeter HeiduschkaKarl Ulrich Bartz‐SchmidtFocke ZiemssenSwaantje PetersEfdal Yoeruek
- Topics
- Retinal Diseases and Treatments (32 papers)Retinal Development and Disorders (29 papers)Glaucoma and retinal disorders (12 papers)
In The Last Decade
Sylvie Julien
57 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 94
- Ophthalmology 1.0k
- Radiology, Nuclear Medicine and Imaging 701
- Molecular Biology 590
- Cellular and Molecular Neuroscience 189
- Immunology 152
Countries citing papers authored by Sylvie Julien
This map shows the geographic impact of Sylvie Julien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Julien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Julien more than expected).
Fields of papers citing papers by Sylvie Julien
This network shows the impact of papers produced by Sylvie Julien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Julien. The network helps show where Sylvie Julien may publish in the future.
Co-authorship network of co-authors of Sylvie Julien
This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Julien. A scholar is included among the top collaborators of Sylvie Julien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Julien. Sylvie Julien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 14 | |
| 4 | 4 | |
| 5 | 22 | |
| 6 | Stabilization and supporting blood vessel growth as a new concept to treat wet AMD | 1 |
| 7 | Testing a new pharmacological therapy approach for the removal of lipofuscin in vitro: results from a newly established culture of aged primary Stargardt mouse model RPE cells and aged primary human RPE cells | 1 |
| 8 | 0 | |
| 9 | 10 | |
| 10 | Choroidal neovascularization can help photoreceptors to survive in late AMD. | 0 |
| 11 | 27 | |
| 12 | 42 | |
| 13 | Rescue of Degenerating Photoreceptors in the RCS Rat by an AAV2/4-RPE65-Mertk Vector | 1 |
| 14 | Lipofuscin Can Be Eliminated From Retinal Pigment Epithelium After Drug Treatment | 1 |
| 15 | 57 | |
| 16 | Effects of Combined- vs. Monotherapy in CNV-Induced Albino Rabbits | 1 |
| 17 | Evidence For Transport Of Bevacizumab (Avastin) Through The Retina By Muller Cells In Rabbits | 2 |
| 18 | 47 | |
| 19 | 44 | |
| 20 | 14 |
About Sylvie Julien
Sylvie Julien is a scholar working on Ophthalmology, Developmental Neuroscience and Physiology, having authored 60 papers that have together received 1.6k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (32 papers), Retinal Development and Disorders (29 papers) and Glaucoma and retinal disorders (12 papers). The work is most often cited by research in Ophthalmology (1.0k citations), Radiology, Nuclear Medicine and Imaging (701 citations) and Developmental Neuroscience (70 citations). Sylvie Julien has collaborated with scholars based in Germany, France and India. Frequent co-authors include Ulrich Schraermeyer, Antje Biesemeier, Tatjana Taubitz, Peter Heiduschka, Karl Ulrich Bartz‐Schmidt, Focke Ziemssen, Swaantje Peters, Efdal Yoeruek, Sabine Hofmeister and Alexander Tschulakow. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.